Underutilization of anthracyclines in the management of HER2-overexpressing advanced breast cancer patients

被引：0
|
作者：
Montemurro, F.
Redana, S.
Valabrega, G.
Donadio, M.
Jacomuzzi, M. E.
Vietti-Ramus, G.
Clavarezza, M.
Danese, S.
Durando, A.
Venturini, M.
Aglietta, M.
机构：
[1] Inst Canc Res & Treatment, Candiolo, Italy
[2] Molinette Mauriziano Hosp, Ctr Oncol Subalpino COES, Turin, Italy
[3] Mauriziano Hosp, Turin, Italy
[4] Giovanni Bosco Hosp, Turin, Italy
[5] Ist Nazl Tumori, Senol Dis Management Team, Genoa, Italy
[6] St Anna Hosp, Turin, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI9 / XI10
页数：2
相关论文
共 50 条
  • [41] Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells
    K Mann
    M Kullberg
    Cancer Gene Therapy, 2016, 23 : 221 - 228
  • [42] Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
    Shattuck, David L.
    Miller, Jamie K.
    Carraway, Kermit L., III
    Sweeney, Colleen
    CANCER RESEARCH, 2008, 68 (05) : 1471 - 1477
  • [43] Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer
    Ewer, Michael S.
    O'Shaughnessy, Joyce A.
    CLINICAL BREAST CANCER, 2007, 7 (08) : 600 - 607
  • [44] Lapatinib A Review of its Use in the Treatment of HER2-Overexpressing, Trastuzumab-Refractory, Advanced or Metastatic Breast Cancer
    Frampton, James E.
    DRUGS, 2009, 69 (15) : 2125 - 2148
  • [45] A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer
    Montemurro, F
    Choa, G
    Faggiuolo, R
    Donadio, M
    Minischetti, M
    Durando, A
    Capaldi, A
    Vietti-Ramus, G
    Alabiso, O
    Aglietta, M
    ONCOLOGY, 2004, 66 (01) : 38 - 45
  • [46] LapatinibA Review of its Use in the Treatment of HER2-Overexpressing, Trastuzumab-Refractory, Advanced or Metastatic Breast Cancer
    James E. Frampton
    Drugs, 2009, 69 : 2125 - 2148
  • [47] Predictors of Locoregional Outcome in HER2-Overexpressing Breast Cancer Treated With Neoadjuvant Chemotherapy
    Arsenault, Daniel
    Hurley, Judith
    Takita, Cristiane
    Reis, Isildinha M.
    Zhao, Wei
    Rodgers, Steven
    Wright, Jean L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 348 - 352
  • [48] Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
    Burstein, HJ
    Kuter, I
    Campos, SM
    Gelman, RS
    Tribou, L
    Parker, LM
    Manola, J
    Younger, J
    Matulonis, U
    Bunnell, CA
    Partridge, AH
    Richardson, PG
    Clarke, K
    Shulman, LN
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2722 - 2730
  • [49] Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells
    Minh Truong Do
    Kim, Hyung Gyun
    Choi, Jae Ho
    Khanal, Tilak
    Park, Bong Hwan
    Thu Phuong Tran
    Jeong, Tae Cheon
    Jeong, Hye Gwang
    FOOD CHEMISTRY, 2013, 141 (03) : 2591 - 2599
  • [50] Synthesis of Quinazoline Analogues with Differential Activity for HER2-overexpressing Breast Cancer Cells
    Jang, Sun-Young
    Lee, Seul
    Kim, Mira
    Ham, Young Jin
    Cha, Mi Young
    Suh, Kwee Hyun
    Kim, Young Hoon
    Kwon, Ara
    Kang, Hae Ju
    Min, Kyung Hoon
    Lee, Kwang-Ok
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2015, 36 (07): : 1933 - 1935
12345